Stachartin B is primarily studied for its potential bioactive properties, particularly in the field of natural product pharmacology. It has shown promising antimicrobial activity against certain Gram-positive bacteria, making it a candidate for development in anti-infective therapies. Additionally, preliminary research indicates possible anti-inflammatory effects, which could be leveraged in treating chronic inflammatory conditions. Due to its natural origin and structural complexity, Stachartin B is also used as a lead compound in drug discovery efforts, aiding in the design of novel synthetic analogs with enhanced stability and efficacy. Its application remains largely in the research phase, with ongoing studies exploring its full therapeutic potential and mechanism of action.